News releases - Merck.com
网页4 天之前 · FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM) September 17, 2024.
FDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a First-in …
网页2024年3月26日 · WINREVAIR is the first FDA-approved activin signaling inhibitor therapy for PAH, representing a new class of therapy that works by improving the balance between pro- and anti-proliferative signaling to regulate vascular cell proliferation underlying PAH. WINREVAIR logo (Graphic: Merck & Co., Inc.)
Merck Provides Update on Phase 3 MOVe-AHEAD Trial Evaluating …
网页2023年2月21日 · MOVe-AHEAD (MK-4482-013) (NCT04939428) was a Phase 3 multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of orally administered LAGEVRIO (molnupiravir) compared to placebo in preventing the spread of SARS-CoV-2, the virus that causes COVID-19, within households.
Merck Enters Two Strategic Collaborations to Strengthen AI …
网页2023年9月20日 · Merck, a leading science and technology company, today announced two new strategic drug discovery collaborations aimed at harnessing powerful artificial intelligence (AI)-driven design and discovery capabilities, further advancing the company’s research efforts.
News & Stories - Merck
网页2024年9月16日 · Check out the latest Merck news and stories! Learn more about the leading science and technology company here.
Merck Receives Priority Review from FDA for New Biologics …
网页2023年9月28日 · RAHWAY, N.J.-- ( BUSINESS WIRE )--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has accepted for...
Merck’s $11.5 Billion Bet on Its Next Big Drug Finally Arrives
网页2024年3月26日 · Merck MRK 0.53% is making a big bet that its new drug, approved Tuesday in the U.S. for a potentially fatal lung disease, will take the company a long way toward heading off a massive revenue ...
FDA approves Merck's drug for rare, deadly lung condition
网页2024年3月26日 · The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the drugmaker and for patients...
Merck Launches First Ever AI Solution to Integrate Drug Discovery …
网页2023年12月5日 · Merck, a leading science and technology company, today launched its AIDDISON™ drug discovery software, the first software-as-a-service platform that bridges the gap between virtual molecule ...
Merck’s fourth-quarter results top estimates, fueled by key cancer ...
网页2024年2月1日 · Merck on Thursday reported fourth-quarter earnings and sales that beat analyst expectations, powered by strong growth in cancer and vaccine products.